Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 464 entries
Sorted by: Best Match Show Resources per page
Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.

OncoTargets and therapy

Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K.
PMID: 24124381
Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013.

Bevacizumab when combined with chemotherapy exerts significant activity against many solid tumors through tumor angiogenesis inhibition; however, it can induce severe side effects. We report the rare case of a 27-year-old premenopausal woman with locally advanced breast cancer that...

Cite
Ono M, Ito T, Kanai T, et al. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013;6:1393-8doi: 10.2147/OTT.S51164.
Ono, M., Ito, T., Kanai, T., Murayama, K., Koyama, H., Maeno, K., Mochizuki, Y., Iesato, A., Hanamura, T., Okada, T., Watanabe, T., & Ito, K. (2013). Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. OncoTargets and therapy, 61393-8. https://doi.org/10.2147/OTT.S51164
Ono, Mayu, et al. "Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer." OncoTargets and therapy vol. 6 (2013): 1393-8. doi: https://doi.org/10.2147/OTT.S51164
Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013. PMID: 24124381; PMCID: PMC3794845.
Copy Download .nbib Format: NLM
Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population.

Yonago acta medica

Yokogi S, Tsubota T, Kanki K, Azumi J, Itaba N, Oka H, Morimoto M, Ryoke K, Shiota G.
PMID: 27493479
Yonago Acta Med. 2016 Jun 29;59(2):93-9. eCollection 2016 Jun.

BACKGROUND: Oral squamous cell carcinoma is a prevalent and frequently lethal malignancy worldwide. Existence of treatment-resistant cancer stem cells is considered to be associated with tumor formation, recurrence and metastasis. Wnt/beta-catenin signal is one of the crucial signaling pathways...

Cite
Yokogi S, Tsubota T, Kanki K, et al. Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population. Yonago Acta Med. 2016;59(2):93-9
Yokogi, S., Tsubota, T., Kanki, K., Azumi, J., Itaba, N., Oka, H., Morimoto, M., Ryoke, K., & Shiota, G. (2016). Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population. Yonago acta medica, 59(2), 93-9.
Yokogi, Satoshi, et al. "Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population." Yonago acta medica vol. 59,2 (2016): 93-9.
Yokogi S, Tsubota T, Kanki K, Azumi J, Itaba N, Oka H, Morimoto M, Ryoke K, Shiota G. Wnt/Beta-Catenin Signal Inhibitor HC-1 Sensitizes Oral Squamous Cell Carcinoma Cells to 5-Fluorouracil through Reduction of CD44-Positive Population. Yonago Acta Med. 2016 Jun 29;59(2):93-9. eCollection 2016 Jun. PMID: 27493479; PMCID: PMC4973014.
Copy Download .nbib Format: NLM
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T.
PMID: 28927133
Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18.

Rebiopsy is considered an option for specific types of cancer, such as breast, non-small cell lung, and prostate cancer, in clinical trials and in practice. The benefit of rebiopsy comes from the selection of a new treatment strategy based...

Cite
Kawasaki K, Hamamoto Y, Suzuki T, et al. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017;14(3):3697-3700doi: 10.3892/ol.2017.6601.
Kawasaki, K., Hamamoto, Y., Suzuki, T., Hirata, K., Sukawa, Y., Kasuga, A., Hayashi, Y., Takaishi, H., Kameyama, K., & Kanai, T. (2017). Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncology letters, 14(3), 3697-3700. https://doi.org/10.3892/ol.2017.6601
Kawasaki, Kenta, et al. "Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report." Oncology letters vol. 14,3 (2017): 3697-3700. doi: https://doi.org/10.3892/ol.2017.6601
Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18. PMID: 28927133; PMCID: PMC5587936.
Copy Download .nbib Format: NLM
Influence of regular exercise on gastric emptying in healthy men: a pilot study.

Journal of clinical biochemistry and nutrition

Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T.
PMID: 27698540
J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16.

Functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD), are common chronic disorders even in the younger population. Physical activity is advocated for patients with FGIDs, although the evidence is insufficient. We investigated the association between the intensity of regular...

Cite
Matsuzaki J, Suzuki H, Masaoka T, et al. Influence of regular exercise on gastric emptying in healthy men: a pilot study. J Clin Biochem Nutr. 2016;59(2):130-133doi: 10.3164/jcbn.16-29.
Matsuzaki, J., Suzuki, H., Masaoka, T., Tanaka, K., Mori, H., & Kanai, T. (2016). Influence of regular exercise on gastric emptying in healthy men: a pilot study. Journal of clinical biochemistry and nutrition, 59(2), 130-133. https://doi.org/10.3164/jcbn.16-29
Matsuzaki, Juntaro, et al. "Influence of regular exercise on gastric emptying in healthy men: a pilot study." Journal of clinical biochemistry and nutrition vol. 59,2 (2016): 130-133. doi: https://doi.org/10.3164/jcbn.16-29
Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T. Influence of regular exercise on gastric emptying in healthy men: a pilot study. J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16. PMID: 27698540; PMCID: PMC5018576.
Copy Download .nbib Format: NLM
Markedly divergent estimates of Amazon forest carbon density from ground plots and satellites.

Global ecology and biogeography : a journal of macroecology

Mitchard ET, Feldpausch TR, Brienen RJ, Lopez-Gonzalez G, Monteagudo A, Baker TR, Lewis SL, Lloyd J, Quesada CA, Gloor M, Ter Steege H, Meir P, Alvarez E, Araujo-Murakami A, Aragão LE, Arroyo L, Aymard G, Banki O, Bonal D, Brown S, Brown FI, Cerón CE, Chama Moscoso V, Chave J, Comiskey JA, Cornejo F, Corrales Medina M, Da Costa L, Costa FR, Di Fiore A, Domingues TF, Erwin TL, Frederickson T, Higuchi N, Honorio Coronado EN, Killeen TJ, Laurance WF, Levis C, Magnusson WE, Marimon BS, Marimon Junior BH, Mendoza Polo I, Mishra P, Nascimento MT, Neill D, Núñez Vargas MP, Palacios WA, Parada A, Pardo Molina G, Peña-Claros M, Pitman N, Peres CA, Poorter L, Prieto A, Ramirez-Angulo H, Restrepo Correa Z, Roopsind A, Roucoux KH, Rudas A, Salomão RP, Schietti J, Silveira M, de Souza PF, Steininger MK, Stropp J, Terborgh J, Thomas R, Toledo M, Torres-Lezama A, van Andel TR, van der Heijden GM, Vieira IC, Vieira S, Vilanova-Torre E, Vos VA, Wang O, Zartman CE, Malhi Y, Phillips OL.
PMID: 26430387
Glob Ecol Biogeogr. 2014 Aug;23(8):935-946. doi: 10.1111/geb.12168. Epub 2014 Apr 22.

AIM: The accurate mapping of forest carbon stocks is essential for understanding the global carbon cycle, for assessing emissions from deforestation, and for rational land-use planning. Remote sensing (RS) is currently the key tool for this purpose, but RS...

Cite
Mitchard ET, Feldpausch TR, Brienen RJ, et al. Markedly divergent estimates of Amazon forest carbon density from ground plots and satellites. Glob Ecol Biogeogr. 2014;23(8):935-946doi: 10.1111/geb.12168.
Mitchard, E. T., Feldpausch, T. R., Brienen, R. J., Lopez-Gonzalez, G., Monteagudo, A., Baker, T. R., Lewis, S. L., Lloyd, J., Quesada, C. A., Gloor, M., Ter Steege, H., Meir, P., Alvarez, E., Araujo-Murakami, A., Aragão, L. E., Arroyo, L., Aymard, G., Banki, O., Bonal, D., Brown, S., Brown, F. I., Cerón, C. E., Chama Moscoso, V., Chave, J., Comiskey, J. A., Cornejo, F., Corrales Medina, M., Da Costa, L., Costa, F. R., Di Fiore, A., Domingues, T. F., Erwin, T. L., Frederickson, T., Higuchi, N., Honorio Coronado, E. N., Killeen, T. J., Laurance, W. F., Levis, C., Magnusson, W. E., Marimon, B. S., Marimon Junior, B. H., Mendoza Polo, I., Mishra, P., Nascimento, M. T., Neill, D., Núñez Vargas, M. P., Palacios, W. A., Parada, A., Pardo Molina, G., Peña-Claros, M., Pitman, N., Peres, C. A., Poorter, L., Prieto, A., Ramirez-Angulo, H., Restrepo Correa, Z., Roopsind, A., Roucoux, K. H., Rudas, A., Salomão, R. P., Schietti, J., Silveira, M., de Souza, P. F., Steininger, M. K., Stropp, J., Terborgh, J., Thomas, R., Toledo, M., Torres-Lezama, A., van Andel, T. R., van der Heijden, G. M., Vieira, I. C., Vieira, S., Vilanova-Torre, E., Vos, V. A., Wang, O., Zartman, C. E., Malhi, Y., & Phillips, O. L. (2014). Markedly divergent estimates of Amazon forest carbon density from ground plots and satellites. Global ecology and biogeography : a journal of macroecology, 23(8), 935-946. https://doi.org/10.1111/geb.12168
Mitchard, Edward T A, et al. "Markedly divergent estimates of Amazon forest carbon density from ground plots and satellites." Global ecology and biogeography : a journal of macroecology vol. 23,8 (2014): 935-946. doi: https://doi.org/10.1111/geb.12168
Mitchard ET, Feldpausch TR, Brienen RJ, Lopez-Gonzalez G, Monteagudo A, Baker TR, Lewis SL, Lloyd J, Quesada CA, Gloor M, Ter Steege H, Meir P, Alvarez E, Araujo-Murakami A, Aragão LE, Arroyo L, Aymard G, Banki O, Bonal D, Brown S, Brown FI, Cerón CE, Chama Moscoso V, Chave J, Comiskey JA, Cornejo F, Corrales Medina M, Da Costa L, Costa FR, Di Fiore A, Domingues TF, Erwin TL, Frederickson T, Higuchi N, Honorio Coronado EN, Killeen TJ, Laurance WF, Levis C, Magnusson WE, Marimon BS, Marimon Junior BH, Mendoza Polo I, Mishra P, Nascimento MT, Neill D, Núñez Vargas MP, Palacios WA, Parada A, Pardo Molina G, Peña-Claros M, Pitman N, Peres CA, Poorter L, Prieto A, Ramirez-Angulo H, Restrepo Correa Z, Roopsind A, Roucoux KH, Rudas A, Salomão RP, Schietti J, Silveira M, de Souza PF, Steininger MK, Stropp J, Terborgh J, Thomas R, Toledo M, Torres-Lezama A, van Andel TR, van der Heijden GM, Vieira IC, Vieira S, Vilanova-Torre E, Vos VA, Wang O, Zartman CE, Malhi Y, Phillips OL. Markedly divergent estimates of Amazon forest carbon density from ground plots and satellites. Glob Ecol Biogeogr. 2014 Aug;23(8):935-946. doi: 10.1111/geb.12168. Epub 2014 Apr 22. PMID: 26430387; PMCID: PMC4579864.
Copy Download .nbib Format: NLM
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8.

Oncoimmunology

Vassilev L, Ranki T, Joensuu T, Jäger E, Karbach J, Wahle C, Partanen K, Kairemo K, Alanko T, Turkki R, Linder N, Lundin J, Ristimäki A, Kankainen M, Hemminki A, Backman C, Dienel K, von Euler M, Haavisto E, Hakonen T, Juhila J, Jäderberg M, Priha P, Vuolanto A, Pesonen S.
PMID: 26140248
Oncoimmunology. 2015 Apr 01;4(7):e1017702. doi: 10.1080/2162402X.2015.1017702. eCollection 2015 Jul.

Adenoviruses are excellent immunotherapeutic agents with a unique ability to prime and boost immune responses. Recombinant adenoviruses cause immunogenic cancer cell death and subsequent release of tumor antigens for antigen presenting cells, resulting in the priming of potent tumor-specific...

Cite
Vassilev L, Ranki T, Joensuu T, et al. Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8. Oncoimmunology. 2015;4(7):e1017702doi: 10.1080/2162402X.2015.1017702.
Vassilev, L., Ranki, T., Joensuu, T., Jäger, E., Karbach, J., Wahle, C., Partanen, K., Kairemo, K., Alanko, T., Turkki, R., Linder, N., Lundin, J., Ristimäki, A., Kankainen, M., Hemminki, A., Backman, C., Dienel, K., von Euler, M., Haavisto, E., Hakonen, T., Juhila, J., Jäderberg, M., Priha, P., Vuolanto, A., & Pesonen, S. (2015). Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8. Oncoimmunology, 4(7), e1017702. https://doi.org/10.1080/2162402X.2015.1017702
Vassilev, L, et al. "Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8." Oncoimmunology vol. 4,7 (2015): e1017702. doi: https://doi.org/10.1080/2162402X.2015.1017702
Vassilev L, Ranki T, Joensuu T, Jäger E, Karbach J, Wahle C, Partanen K, Kairemo K, Alanko T, Turkki R, Linder N, Lundin J, Ristimäki A, Kankainen M, Hemminki A, Backman C, Dienel K, von Euler M, Haavisto E, Hakonen T, Juhila J, Jäderberg M, Priha P, Vuolanto A, Pesonen S. Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8. Oncoimmunology. 2015 Apr 01;4(7):e1017702. doi: 10.1080/2162402X.2015.1017702. eCollection 2015 Jul. PMID: 26140248; PMCID: PMC4485730.
Copy Download .nbib Format: NLM
Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes.

Hepatology research : the official journal of the Japan Society of Hepatology

Higuchi Y, Kawai K, Kanaki T, Yamazaki H, Chesné C, Guguen-Guillouzo C, Suemizu H.
PMID: 26724677
Hepatol Res. 2016 Sep;46(10):1045-57. doi: 10.1111/hepr.12644. Epub 2016 Feb 07.

AIM: The hepatoma-derived cell line HepaRG is regarded as an in vitro model of drug metabolism because fully differentiated HepaRG cells demonstrate functional metabolic responses comparable to those of primary human hepatocytes. Recently, it was demonstrated that the 3D...

Cite
Higuchi Y, Kawai K, Kanaki T, et al. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatol Res. 2016;46(10):1045-57doi: 10.1111/hepr.12644.
Higuchi, Y., Kawai, K., Kanaki, T., Yamazaki, H., Chesné, C., Guguen-Guillouzo, C., & Suemizu, H. (2016). Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatology research : the official journal of the Japan Society of Hepatology, 46(10), 1045-57. https://doi.org/10.1111/hepr.12644
Higuchi, Yichiro, et al. "Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,10 (2016): 1045-57. doi: https://doi.org/10.1111/hepr.12644
Higuchi Y, Kawai K, Kanaki T, Yamazaki H, Chesné C, Guguen-Guillouzo C, Suemizu H. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatol Res. 2016 Sep;46(10):1045-57. doi: 10.1111/hepr.12644. Epub 2016 Feb 07. PMID: 26724677.
Copy Download .nbib Format: NLM
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.
PMID: 26870193
Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.

Tumoral cavity formation is a characteristic phenomenon reported in anti-angiogenic therapy in lung lesions. A 57-year-old male with multiple pulmonary metastases from colorectal cancer treated with an oral tyrosine kinase inhibitor, regorafenib, exhibited a characteristic cavity formation after the...

Cite
Kawasaki K, Hamamoto Y, Adachi M, et al. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2015;11(1):231-233doi: 10.3892/ol.2015.3905.
Kawasaki, K., Hamamoto, Y., Adachi, M., Kanai, T., & Takaishi, H. (2016). Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncology letters, 11(1), 231-233. https://doi.org/10.3892/ol.2015.3905
Kawasaki, Kenta, et al. "Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report." Oncology letters vol. 11,1 (2016): 231-233. doi: https://doi.org/10.3892/ol.2015.3905
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10. PMID: 26870193; PMCID: PMC4727027.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.

Hepatology research : the official journal of the Japan Society of Hepatology

Tamada T, Korenaga M, Yamamoto A, Higaki A, Kanki A, Nishina S, Hino K, Ito K.
PMID: 27161283
Hepatol Res. 2017 Mar;47(3):E152-E160. doi: 10.1111/hepr.12742. Epub 2016 Jun 04.

AIM: To clarify the clinical and magnetic resonance imaging (MRI) features of de novo hypervascular hepatocellular carcinoma (HCC) using serial gadoxetic acid-enhanced MRI.METHODS: The institutional review board approved this retrospective study. After review of 1007 MRI examinations in 240...

Cite
Tamada T, Korenaga M, Yamamoto A, et al. Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging. Hepatol Res. 2016;47(3):E152-E160doi: 10.1111/hepr.12742.
Tamada, T., Korenaga, M., Yamamoto, A., Higaki, A., Kanki, A., Nishina, S., Hino, K., & Ito, K. (2017). Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging. Hepatology research : the official journal of the Japan Society of Hepatology, 47(3), E152-E160. https://doi.org/10.1111/hepr.12742
Tamada, Tsutomu, et al. "Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,3 (2017): E152-E160. doi: https://doi.org/10.1111/hepr.12742
Tamada T, Korenaga M, Yamamoto A, Higaki A, Kanki A, Nishina S, Hino K, Ito K. Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging. Hepatol Res. 2017 Mar;47(3):E152-E160. doi: 10.1111/hepr.12742. Epub 2016 Jun 04. PMID: 27161283.
Copy Download .nbib Format: NLM
Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.

Oncology letters

Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T.
PMID: 28599481
Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21.

Patients with pancreatic ductal adenocarcinoma (PDA) typically succumb to mortality early, even following surgical resection. Therefore, prognostic factors associated with early mortality are required to improve the survival of patients with PDA following surgical resection. Carbohydrate sulfotransferase 15 (CHST15)...

Cite
Ito Z, Takakura K, Suka M, et al. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(6):4799-4805doi: 10.3892/ol.2017.6071.
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., Koido, S., & Ohkusa, T. (2017). Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncology letters, 13(6), 4799-4805. https://doi.org/10.3892/ol.2017.6071
Ito, Zensho, et al. "Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma." Oncology letters vol. 13,6 (2017): 4799-4805. doi: https://doi.org/10.3892/ol.2017.6071
Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21. PMID: 28599481; PMCID: PMC5453115.
Copy Download .nbib Format: NLM
Adenomatoid tumor of cervix: The first case report.

Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Banik T, Mondal K, Mandal R.
PMID: 27051161
Indian J Med Paediatr Oncol. 2016 Jan-Mar;37(1):66. doi: 10.4103/0971-5851.177039.

No abstract available.

Cite
Banik T, Mondal K, Mandal R. Adenomatoid tumor of cervix: The first case report. Indian J Med Paediatr Oncol. 2016;37(1):66doi: 10.4103/0971-5851.177039.
Banik, T., Mondal, K., & Mandal, R. (2016). Adenomatoid tumor of cervix: The first case report. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology, 37(1), 66. https://doi.org/10.4103/0971-5851.177039
Banik, Tarak, et al. "Adenomatoid tumor of cervix: The first case report." Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology vol. 37,1 (2016): 66. doi: https://doi.org/10.4103/0971-5851.177039
Banik T, Mondal K, Mandal R. Adenomatoid tumor of cervix: The first case report. Indian J Med Paediatr Oncol. 2016 Jan-Mar;37(1):66. doi: 10.4103/0971-5851.177039. PMID: 27051161; PMCID: PMC4795380.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 464 entries